Form 4 for OLMA Olema Pharmaceuticals, Inc.
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001415889-22-001314 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-14 | 2022-02-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $2.06 | +5,251 | 7,709 | +214% | +$10.8K |
| D | 2022-02-14 | 2022-02-10 | OLMA | Horn Kinney | Chief BUSINESS Off | D - Sale to Iss | — | -5,251 | 2,458 | -68% | — |
| D | 2022-02-14 | 2022-02-10 | OLMA | Horn Kinney | Chief BUSINESS Off | M - OptEx | $0.00 | -5,251 | 147.0K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | M | A | 5,251 | $2.06 | 7,709 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-10 | D | D | 5,251 | — | 2,458 | D | — | — | (F2) The weighted average sale price for the transaction reported was $5.46, and the range of prices were between $5.14 and $5.66. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-10 | M | D | 5,251 | $0.00 | 147,038 | D | $2.06 · — to 2030-11-09 | 5,251 Common Stock | (F3) The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date. |